Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
Eun Hyun Seo, Woon Yeong Park, IL Han Choo
Psychiatry Investig. 2017;14(2):205-215.   Published online 2017 Mar 6     DOI:
Predicting cognitive decline in older people by structural and molecular imaging
Stefan Teipel, Yi Tang, Marina Boccardi
Current Opinion in Neurology.2023; 36(4): 253.     CrossRef
Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review
Lea Daou, Alaeddine El Alayli, Fadi Constantinos, Georgette Dib, Marc Barakat
Biomarkers in Neuropsychiatry.2023; 9: 100069.     CrossRef
Learning potential and visuospatial memory could predict amyloid-beta positron emission tomography positivity in amnestic mild cognitive impairment
Min-Gwan Shin, Young Min Lee, Yoo Jun Kim, Hyunji Lee, Kyoungjune Pak, Kyung-Un Choi
Psychiatry Research: Neuroimaging.2023; 335: 111705.     CrossRef
Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study
Sid E. O’Bryant, Fan Zhang, Melissa Petersen, James R. Hall, Leigh A. Johnson, Kristine Yaffe, Meredith Braskie, Rocky Vig, Arthur W. Toga, Robert A. Rissman
Journal of Alzheimer's Disease.2022; 86(3): 1243.     CrossRef
Systematic Review of Different Neuroimaging Correlates in Mild Cognitive Impairment and Alzheimer’s Disease
Puneet Talwar, Suman Kushwaha, Monali Chaturvedi, Vidur Mahajan
Clinical Neuroradiology.2021; 31(4): 953.     CrossRef
Theory of mind in Alzheimer’s disease and amnestic mild cognitive impairment: a meta-analysis
ZhongQuan Yi, PanWen Zhao, Hui Zhang, YuanYuan Shi, HaiChun Shi, JianGuo Zhong, PingLei Pan
Neurological Sciences.2020; 41(5): 1027.     CrossRef
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer’s Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography
Leonie Beyer, Matthias Brendel, Franziska Scheiwein, Julia Sauerbeck, Chisa Hosakawa, Ian Alberts, Kuangyu Shi, Peter Bartenstein, Kazunari Ishii, John Seibyl, Paul Cumming, Axel Rominger, Valentina Bessi
Journal of Alzheimer's Disease.2020; 74(1): 101.     CrossRef
Insights into Systemic Disease through Retinal Imaging-Based Oculomics
Siegfried K. Wagner, Dun Jack Fu, Livia Faes, Xiaoxuan Liu, Josef Huemer, Hagar Khalid, Daniel Ferraz, Edward Korot, Christopher Kelly, Konstantinos Balaskas, Alastair K. Denniston, Pearse A. Keane
Translational Vision Science & Technology.2020; 9(2): 6.     CrossRef
Real-space navigation testing differentiates between amyloid-positive and -negative aMCI
Florian Schöberl, Cauchy Pradhan, Stephanie Irving, Katharina Buerger, Guoming Xiong, Günter Kugler, Stefan Kohlbecher, Julia Engmann, Philipp Werner, Matthias Brendel, Erich Schneider, Robert Perneczky, Klaus Jahn, Christian la Fougère, Peter Bartenstein
Neurology.2020; 94(8): e861.     CrossRef
Spectral-Domain OCT Measurements in Alzheimer’s Disease
Victor T.T. Chan, Zihan Sun, Shumin Tang, Li Jia Chen, Adrian Wong, Clement C. Tham, Tien Y. Wong, Christopher Chen, M. Kamran Ikram, Heather E. Whitson, Eleonora M. Lad, Vincent C.T. Mok, Carol Y. Cheung
Ophthalmology.2019; 126(4): 497.     CrossRef
Random forest prediction of Alzheimer’s disease using pairwise selection from time series data
P. J. Moore, T. J. Lyons, J. Gallacher, Stephen D Ginsberg
PLOS ONE.2019; 14(2): e0211558.     CrossRef
Bridging the Gap between Alzheimer’s Disease and Alzheimer’s-like Diseases in Animals
Anita Gołaszewska, Wojciech Bik, Tomasz Motyl, Arkadiusz Orzechowski
International Journal of Molecular Sciences.2019; 20(7): 1664.     CrossRef
Three-dimensional pseudocontinuous arterial spin labeling and susceptibility-weighted imaging associated with clinical progression in amnestic mild cognitive impairment and Alzheimer's disease
Qingling Huang, Xuan Cao, Xue Chai, Xiao Wang, Ligang Xu, Chaoyong Xiao
Medicine.2019; 98(23): e15972.     CrossRef
Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects
Sven Haller, Marie-Louise Montandon, Cristelle Rodriguez, Valentina Garibotto, François R. Herrmann, Panteleimon Giannakopoulos
Neurodegenerative Diseases.2019; 19(3-4): 139.     CrossRef